Citi Pharma Ltd. — Investor Relations & Filings
Citi Pharma Ltd. is a prominent pharmaceutical company specializing in the manufacturing and sale of pharmaceuticals, medical chemicals, and botanical products. It is a leading producer of Active Pharmaceutical Ingredients (APIs), with key products including Paracetamol, Penicillin, and Amoxicillin. The company delivers high-quality pharmaceutical services to a global market while maintaining a significant presence in local API manufacturing. Citi Pharma is dedicated to expanding its generic pharmaceutical portfolio and is actively engaged in research and development, notably in developing locally manufactured insulin to reduce import reliance. The company is also strategically advancing into biotechnology and oncology, driven by innovation and strategic collaborations, such as those with the Gates Foundation, to integrate advanced biotech technologies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Material Information | 2026-05-21 | English | |
| Material Information | 2026-05-06 | English | |
| Transmission of Quarterly Report for the Period Ended 31st March 2026 | 2026-04-30 | English | |
| Financial Results for the Quarter Ended 31 March 2026 | 2026-04-30 | English | |
| Material Information | 2026-03-03 | English | |
| Presentation - Corporate Briefing Session | 2026-02-27 | English |
Browse filings by year
6 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
Citi Pharma Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/71782/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=71782 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=71782 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=71782 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 71782}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Citi Pharma Ltd. (id: 71782)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.